| Position | Action |
|---|---|
| 50 SMA at $81.35 fails on rising volume (>10M shares) | Trim 15-20% of position |
GM at $87.58 represents a deeply undervalued trough-to-recovery trade, with a Forward P/E of 5.95x, PEG of 0.35, and $21.93B TTM FCF providing a compelling risk-reward setup as margin expansion and charging network scale drive mean reversion from 2025's trough.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 86.95 | bullish |
| close_50_sma | 81.35 | bullish |
| close_200_sma | 77.91 | bullish |
| rsi | 60.88 | bullish |
| macd | 2.62 | bullish |
| macdh | +0.33 | neutral |
| boll_ub | 94.19 | bullish |
| vwma | 85.53 | bullish |
| atr | 2.63 | neutral |
Support: 85.5 · 83.64 · 82.32 · 81.35 · 77.91 | Resistance: 90.3 · 91.85 · 94.19 · 100
GM shows strong bullish technicals with all moving averages positively stacked and price above each. RSI at 60.88 indicates healthy bullish momentum without overbought extremes. MACD is positive at 2.62 with histogram shrinking to +0.33, signaling momentum deceleration but no reversal. The stock is consolidating after a breakout to $91.85 (July 28, 2026) with key support at $85.50 and upside target at $94.19. Final stance is HOLD for existing positions; new entries recommended on pullbacks to $84-86 or breakouts above $90.30.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain GM exposure at ~$87.58; refine stop to $84.50, add trim rule at 50 SMA, preserve two-tier re-engagement framework
This is a 3-6 month setup. The catalyst path (full-year 2026 earnings, 2025 trough washing out of trailing metrics, charging network milestones) plays out over multiple quarters. Patience is required, but must be paired with defined re-engagement triggers: confirmed break above $91.85 on volume >10M shares upgrades to Overweight; pullback to 50 SMA with RSI reset to 40-45 and MACD stabilization upgrades to Buy with -7% entry and -11% to 200 SMA floor at $77.91.
· concedes: The 2025 operating margin of 1.6% and net income collapse to $2.7B are real and represent the trough the bull case is built upon; The TTM P/E of 39.10 is distorted by the Q4 2025 loss and requires looking through to forward earnings; The MACD histogram is shrinking from +1.50 to +0.33, which could be misread as weakening momentum (though bull argues it's healthy post-breakout consolidation); The EV-demand environment in China is contested; Sustained high rates pressure auto financing costs, though GM Financial captive financing provides a differential advantage
GM at $87.58 is a cyclical value trap dressed as a recovery story—the +69.5% YTD rally was driven by CapEx cuts and EV write-downs, not improving fundamentals, and the 5.95x forward P/E requires peak earnings delivery in an environment of weakening demand, rising rates, and intensifying EV competition.
· concedes: The 300-site, 1,300-stall charging network is operational (though it's a JV with Pilot/EVgo, not GM-exclusive, and represents only 4% of Tesla's 50,000+ stall network); Q1 2026 net income of $2.63B was the strongest quarter in the dataset; The $77.91 200 SMA level represents a real structural floor if fundamentals confirm; The tariff relief probability (88%) does reduce one headwind; Magna, BorgWarner, Lear, and Garrett supplier beats were cited as mildly bullish (though backward-looking)
→ vs conservative: Sequential Q1-to-Q2 earnings decline is not weakness but normalization after one-time restructuring charges in Q4 2025; earnings power remains intact
→ vs conservative: Three failed retests of $91.85 are not a lower high pattern but resistance absorption with buyers holding above $86, building energy for breakout
→ vs conservative: No Fed cuts is actually a tailwind for GM Financial's spread environment and consumer credit quality is holding up
→ vs neutral: 78% MACD histogram collapse from $1.50 to $0.33 is mandatory digestion after a vertical rally from $75 to $91.85, not a bearish signal when MACD line remains well above zero
→ vs conservative: Waiting for perfect confirmation means paying higher prices; the fundamental, technical, and catalyst alignment is already obvious
Market Cap
$79.21B
Share Price (Implied)
~$87.6
52-Week High
$91.85
52-Week Low
$53.09
50-Day Moving Average
$80.73
200-Day Moving Average
$77.55
Beta
1.33
P/E (TTM)
39.10
Forward P/E
5.95
PEG Ratio
0.35
P/B
1.24
Dividend Yield
0.83%
Book Value per Share
$70.70
TTM Revenue
$185.53B
Q2 2026 Revenue
$48.03B
2025 Annual Revenue
$185.02B
2024 Annual Revenue
$187.44B
TTM Net Income
$1.86B
TTM EBITDA
$16.46B
TTM Operating Margin
3.20%
TTM Net Margin
1.05%
TTM Gross Margin
~10.2%
TTM EBITDA Margin
~8.9%
ROE
3.16%
ROA
2.25%
2025 Annual Operating Income
$2.91B
2025 Annual Operating Margin
1.6%
2025 EPS
$3.27
2024 EPS
$6.37
2023 EPS
$7.32
Q1 2026 Net Income
$2.63B
Q2 2026 Net Income
$1.31B
Q4 2025 Net Income
-$3.31B
Q4 2025 Gross Loss
-$1.12B
Q4 2025 Operating Loss
-$3.65B
Total Assets
$282.74B
Cash & Equivalents
$20.13B
Short-Term Investments
$4.6B
Inventory
$16.0B
Receivables
$61.6B
Total Debt
$127.70B
Net Debt
$107.56B
Stockholders' Equity
$62.00B
Debt-to-Equity
202.3%
Current Ratio
1.14
Working Capital
$13.2B
TTM Free Cash Flow
$21.93B
Q2 2026 OCF
$6.35B
Q2 2026 CapEx
-$5.26B
Q2 2026 FCF
$1.10B
Q1 2026 FCF
-$1.84B
TTM Buybacks
~$6.30B
TTM Dividends
~$1.29B
Q2 2025 CapEx
-$12.54B
Cruise Equity Investment Loss
-$4.68B
Strengths
Concerns
GM presents a mixed but cautiously constructive fundamental picture with 2025 representing a cyclical and strategic trough marked by 73% net income decline, margin compression to 1.6% operating margin, and a $4.68B Cruise loss; however, management's response—aggressive CapEx cuts from $12.5B to $5.3B per quarter, ~$6B in annual buybacks, $8B debt reduction, and strong TTM FCF of $21.93B—provides a credible recovery playbook. The market is already pricing in substantial recovery at a forward P/E of ~6× with the stock near its 52-week high, offering asymmetric reward for patient capital but requiring staged entry given high cyclical and tariff risks. Suggested posture: Maintain/accumulate on weakness toward 50-day MA ($80.73); avoid chasing into 52-week high ($91.85) without confirmed earnings catalyst.